Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 103 results
A minimalist illustration of a brain and neurons representing AI in diagnostics.

Jun 8, 2026

How new AI tool could prevent diagnostic mistakes

A recent study has introduced an AI tool aimed at enhancing diagnostic accuracy for Alzheimer's disease and related dementias, indicating a significant advancement in clinical practices.The Automated Imaging Differentiation of Dementia (AIDD) tool leverages advanced imaging and AI to effectively differentiate between Alzheimer’s disease and dementia with Lewy bodies. This distinction is critical, as the two forms of dementia exhibit different symptoms and require varied treatment approaches. Mis
A minimalist representation of a cancer cell and AI technology in flat design.

Jun 8, 2026

AI in Oncology Market to Value USD 54.71 Billion by 2035, Expanding at 26.23% - SNS Insider

The AI in oncology market is projected to experience significant growth, with an expected value of USD 54.71 billion by 2035, expanding at a compound annual growth rate (CAGR) of 26.23% from 2026 to 2035. This surge is primarily attributed to the increasing global cancer incidence, the rise in precision medicine adoption, and the integration of AI technologies in cancer diagnostics and treatment planning.Currently, over 20 million new cancer cases are diagnosed each year, prompting healthcare pr
Minimalist illustration of a prostate gland and biopsy needle on a dark background.

Jun 8, 2026

M42 brings AI-driven prostate cancer diagnostics to the UAE

M42 is introducing AI-enhanced diagnostics for prostate cancer in the UAE, addressing a significant health challenge in the region.Prostate cancer is increasingly prevalent in the Middle East, with officials reporting around 50,000 new cases annually. The traditional methods for reviewing and grading biopsies are often intricate and lengthy, which can result in delays in obtaining diagnoses for patients. M42's AI-driven approach aims to streamline this process, potentially improving both accurac
A medical imaging device in a dimly lit hospital corridor

Jun 5, 2026

Philips and WellSpan Health Launch 7-Year Strategic AI and Imaging Partnership

Philips and WellSpan Health have forged a seven-year strategic partnership aimed at enhancing healthcare delivery through advanced imaging and AI technologies.This collaboration marks a pioneering step as it is the first joint innovation initiative between Philips and a U.S. community health system. Unlike traditional vendor relationships, Philips will engage directly with WellSpan to co-develop AI-driven healthcare solutions tailored for community care settings. The partnership encompasses all
MRI machine in a dimly lit hospital corridor

Jun 5, 2026

WellSpan Health & Philips Collaborate to Advance AI, Imaging & Diagnostics

WellSpan Health and Philips have formed a seven-year collaboration aimed at enhancing imaging and diagnostics technology across Central Pennsylvania and Northern Maryland.This partnership marks the first of its kind between Philips and a U.S. community health system, integrating a research agreement, joint innovation strategy, and a long-term commercial relationship. The focus will be on validating AI and digital tools designed to improve hospital efficiency, including throughput, costs, and wor
A minimalist illustration of a cancer cell and imaging system on a dark background.

Jun 5, 2026

AI-Powered Imaging Systems and Deep Learning Software Revolutionize Cancer Diagnostics Market Globally

The AI in cancer diagnostics market is poised for significant growth, driven by advancements in technology and increasing demand for early detection solutions.According to recent projections, the market is expected to increase from $0.79 billion in 2025 to $0.96 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.2%. This growth is attributed to the rising incidence of cancer globally, with the National Cancer Institute forecasting 2 million new cases in the U.S. by 2024 and 29
Minimalist representation of a PD-L1 antibody

Jun 5, 2026

AI collaboration to advance digital pathology

Leica Biosystems, Indica Labs, and Lunit have announced a strategic partnership aimed at enhancing digital pathology through AI-powered image analysis algorithms, particularly for PD-L1 and other immunohistochemistry biomarkers.This collaboration builds on an existing relationship between Leica Biosystems and Indica Labs, now integrating Lunit’s advanced AI technology into a comprehensive digital pathology ecosystem. The initial product from this partnership is the Lunit SCOPE algorithm, designe
Flat design of a radiology report with an imaging insight icon

Jun 3, 2026

Cortechs.ai, Microsoft Collaborate to Bring AI-Powered Imaging Insights into Radiology Workflows

Cortechs.ai has entered into a strategic partnership with Microsoft to enhance radiology workflows through the integration of AI-powered imaging insights and biomarkers. This initiative aims to improve diagnostic accuracy, streamline reporting processes, and expedite clinical decision-making across healthcare settings.The collaboration seeks to embed Cortechs.ai's quantitative imaging applications into Microsoft's existing radiology reporting tools, allowing clinicians to access valuable imaging
A blood smear on a microscope slide in a lab setting

Jun 3, 2026

AI-Powered Pathology Research Advances Diagnostics In South Africa

The National Health Laboratory Service (NHLS) in South Africa is embarking on an ambitious initiative to integrate artificial intelligence (AI) into pathology research, aiming to enhance diagnostic accuracy and efficiency within the public healthcare system.This initiative is part of a broader strategy to modernize laboratory medicine, with a particular focus on haematopathology. Traditionally, diagnosing conditions like multiple myeloma has been labor-intensive and subject to variability, espec
Flat design of TROP2 biomarker and assay

Jun 3, 2026

Leica Biosystems Announces Expansion of Collaboration to Scale Precision Medicine and Develop AI-Powered Diagnostics

Leica Biosystems is enhancing its collaboration with AstraZeneca and Daiichi Sankyo to advance precision medicine through the development of AI-driven diagnostics for non-small cell lung cancer.The expansion of this partnership, initially established in May 2025, focuses on the creation of an immunohistochemistry (IHC) assay and image analysis algorithm targeting the TROP2 Normalized Membrane Ratio (NMR) biomarker. This initiative aims to provide a comprehensive research tool that integrates bot
Microscope and tissue sample illustration

Jun 2, 2026

GLOBAL PATHOLOGY, DIAGNOSTICS & LABORATORY MEDICINE CONFERENCE & BUSINESS EXPO: INNOVATION, INVESTMENT, AND INDUSTRY PARTNERSHIPS

The upcoming Global Pathology, Diagnostics & Laboratory Medicine Conference & Business Expo in 2026 aims to unite professionals from various sectors within the life sciences industry, including pathologists, researchers, and healthcare providers. This event is set to be a significant platform for discussing advancements and innovations in pathology and diagnostics.The conference will feature a range of activities such as keynote speeches, scientific presentations, and interactive workshops. Thes
A flat illustration of a chest CT scan and lungs in a minimalist style.

Jun 1, 2026

contextflow: MedTech Giant 4DMedical Acquires Vienna Startup for More Than €11.4 Million

4DMedical Limited has announced the acquisition of the Vienna-based startup contextflow for over €11.4 million, marking a strategic expansion into the European market.Founded in 2016, contextflow specializes in AI-driven software for lung diagnostics, focusing on conditions like lung cancer and COPD. Its flagship product, ADVANCE Chest CT, utilizes proprietary AI to analyze chest CT scans, aiding healthcare professionals in disease detection and management. The startup has garnered attention for